Fetal DNA Test in Ankara

Fetal DNA testing, also known as NIPT, is a screening test performed using a blood sample taken from the mother during pregnancy. In Ankara, fetal DNA testing can be performed at healthcare centers where blood samples can be collected as part of prenatal care and where the samples can be sent for analysis under appropriate laboratory conditions. For the test to be evaluated correctly, it is important that the gestational age is appropriate, the sample collection conditions are met, and the report is interpreted by a physician.

This test is based on the analysis of free-floating fetal DNA fragments in the mother’s blood. The primary purpose of this test is to assess the likelihood of chromosomal risks, particularly trisomy 21, trisomy 18, and trisomy 13. It is important to remember that the test result alone does not serve as a diagnosis.

When selecting a center to perform the fetal DNA test, the sample collection process and the information-sharing phase should also be taken into account. The expectant mother should be informed about the scope of the test, which chromosomal conditions it evaluates, how the results will be reported, and under what circumstances further testing may be required.

The following points should be evaluated before undergoing the test:

• Whether the gestational age is appropriate for the test
• Which chromosomal risks are included in the test panel
• Whether the result is screening in nature
• How the reporting process proceeds
• What additional evaluations may be required in the event of suspicious results

For more detailed information about this test, please review our NIPT test content.

Who Is Eligible for Fetal DNA Testing in Ankara?

Fetal DNA testing may be recommended by a physician for expectant mothers who plan to undergo chromosomal risk assessment during pregnancy. The test is not specific to a single patient group; however, the decision to perform it should be evaluated in conjunction with factors such as gestational age, previous screening results, ultrasound findings, maternal age, and medical history.

This test is particularly helpful in assessing the likelihood of common chromosomal abnormalities. These may include trisomy 21 (known as Down syndrome), trisomy 18 (known as Edwards syndrome), and trisomy 13 (known as Patau syndrome). Since the scope of the test may vary depending on the panel used, it is important to determine in advance which chromosomes will be analyzed.

A fetal DNA test may be considered, following a physician’s evaluation, in the following situations:

• Pregnancies involving advanced maternal age
• When risk is identified in previous screening tests
• When ultrasound findings indicate the need for further evaluation
• In pregnancies with a history of chromosomal abnormalities
• When the expectant mother wishes to learn about screening options

The appropriateness of this test requires a personalized assessment. The same testing approach may not be followed in every pregnancy. Therefore, the decision to undergo fetal DNA testing should be made under the guidance of the physician managing the pregnancy.

How Does the Fetal DNA Testing Process Work in Ankara?

The fetal DNA testing process in Ankara begins with an evaluation of the gestational age and the suitability of the test. The physician managing the expectant mother’s prenatal care reviews the current screening results, ultrasound findings, and medical history together. After providing information about the scope of the test, a blood sample is scheduled to be drawn.

Fetal DNA testing is generally evaluable starting at the 10th week of pregnancy. Before this week, the amount of fetal DNA in the mother’s blood may not be sufficient for analysis. The blood sample collected at the appropriate week is sent for analysis, and the laboratory evaluation begins. Results may be reported within varying timeframes depending on the scope of the test panel and the laboratory process.

The process generally consists of the following steps:

• Assessment of gestational age and test eligibility
• Informing the expectant mother about the scope of the test
• Collection of the blood sample under appropriate conditions
• Forwarding the sample for laboratory analysis
• Reporting the results on a probability-based basis
• Interpretation of the report by the physician as part of prenatal care

The result may be reported as low-risk, high-risk, or, in some cases, unevaluable. A high-risk result does not constitute a diagnosis. In such cases, if the physician deems it necessary, they may provide information about genetic counseling, detailed ultrasound, or diagnostic testing options.

Fetal DNA Test Prices in Ankara

The cost of a fetal DNA test may vary depending on the scope of the test, the number of chromosomes analyzed, the laboratory method used, and the level of detail in the report. Since there may be differences in content between the standard panel and the expanded panel, a price assessment should be made only after the technical scope of the test has been clarified.

When researching prices, it is not enough to focus solely on cost information. You should also consider which chromosomal risks the test evaluates, how the results are reported, and how the sample collection process is conducted.